The FDA determined that the 3-dose Pfizer COVID-19 vaccine worked in children aged 6 months through 4 years; the bipartisan Senate gun deal will focuses on mental health; the pandemic has other viruses acting mysteriously, with children diagnosed with respiratory viruses in May and June.
The 3-dose COVID-19 vaccine from Pfizer and BioNTech was found to have worked in young children aged 6 months to 4 years, according to The Wall Street Journal. The FDA also found that the data proved that there were no new safety concerns with using the vaccine in young children compared with the rest of the population. This announcement comes mere days from when an FDA staff review found that the Moderna vaccine was also safe for young children of the same age group. These findings could indicate that the vaccine will be made available to this age group soon, with the Biden administration saying that vaccinations for young children could be made available by June 21.
A bipartisan gun deal from Senators Debbie Stabenow (D-Mich.) and Roy Blunt (R-Mo.) would include funding for community mental health clinics nationwide that would provide mental health crisis response, substance abuse treatment, and other services around the clock, according to The Hill. The measure would expand the mental health clinic program, which currently only has 10 states fully participating. The framework released by the 20 senators who are working on the bill called for “major investments to increase access to mental health and suicide prevention programs” although no hard figure was provided.
Viruses which are typically limited to the winter months, including respiratory syncytial virus and the flu, are becoming more common in the summer months, according to The Washington Post. Due to this increase in virus cases outside of their usual season, doctors are thinking of keeping more vaccinesn on hand in the spring and summer. Epidemiologists are also looking into what stay-at-home orders, masking, and social distancing may have done to affect virus cases thereafter. Researchers and doctors suggest that the removal of masks and gatherings held indoors when population immunity was low may have been the cause of the increase in out-of-season virus cases.
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
Frameworks for Advancing Health Equity: Community Wellness Centers
September 27th 2024Delia Orosco, MS, director of Community Wellness Centers at Inland Empire Health Plan, shares insight into innovative initiatives provided by the wellness centers and their new mobile mammogram clinics.
Listen
Rozanolixizumab Effective in Patients with MuSK MG, Analysis Shows
October 23rd 2024A new subgroup analysis of patients with muscle-specific tyrosine kinase (MuSK) autoantibody-positive (Ab+) myasthenia gravis (MG) shows rozanolixizumab (Rystiggo) contributes to meaningful symptom improvement.
Read More